Evaluation of Treatment Success Rate Among Antihyperuricemic Using Real-World Data

被引：0
|
作者：
Teramoto, Kei [1 ]
Takeda, Toshihiro [2 ]
Matsumura, Yasushi [2 ]
Ohtahara, Akira [3 ]
Hisatome, Ichiro [4 ]
Kondoh, Hiroshi [1 ]
机构：
[1] Tottori Univ Hosp, Div Med Informat, 36-1 Nishi Cho, Tottori 6838504, Japan
[2] Osaka Univ, Med Informat, Grad Sch Med, Osaka, Japan
[3] San In Rosai Hosp, Div Cardiol, Tottori, Japan
[4] Tottori Univ, Inst Regenerat Med & Biofunct, Dept Genet Med & Regenerat Therapeut, Div Regenerat Med & Therapeut,Grad Sch Med Sci, Yonago, Tottori, Japan
来源：
MEDINFO 2019: HEALTH AND WELLBEING E-NETWORKS FOR ALL | 2019年 / 264卷
关键词：
Electronic health records; Pharmacoepidemiology; Antihyperuricemics;
D O I：
10.3233/SHTI190385
中图分类号：
TP39 [计算机的应用];
学科分类号：
081203 ; 0835 ;
摘要：
In this study, treatment and the serum uric acid (UA) level were compared using medication history generated by prescription order records of antihyperuricemic to examine the treatment success rate. We examined the treatment success rate among these patients based on the serum UA level during 120-180 days after the initiation of treatment, which was set as the endpoint. The number of patients whose UA level before the start of treatment was > 8.0 mg/dL but decreased to < 6.0 mg/dL after the treatment, which is the target treatment success, was 92 (success rate of 14.2%), 50 (53.2%), 76 (41.5%), 35 (31.9%), and 45 (37.8%) in the allopurinol 100 mg/day (A1) and 200 mg/day (A2), febuxostat 10 mg/day (F1) and 20 mg/day (F2), and benzbromarone 50 mg/day (B), respectively. Compared with that of the other drugs, the treatment success rate was high with A2 and low with A1. From the generated medication history, the treatment success rate with antihyperuricemic can be extracted mechanically.
引用
收藏
页码：1051 / 1055
页数：5
相关论文
共 50 条
  • [21] Defining treatment regimens and lines of therapy using real-world data in oncology
    Hess, Lisa M.
    Li, Xiaohong
    Wu, Yixun
    Goodloe, Robert J.
    Cui, Zhanglin Lin
    FUTURE ONCOLOGY, 2021, 17 (15) : 1865 - 1877
  • [22] A Study on Treatment and Characteristics of Prostate Cancer Patients Using Real-World Data
    Miranda, Jamilette
    Lilja, Birgitta
    Wettermark, Bjoern
    Ljunggren, Gunnar
    Henriksson, Roger
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2015, 24 : 533 - 533
  • [23] REAL-WORLD DATA OF OSTEOPOROTIC TREATMENT WITH ANABOLIC AGENTS
    Lee, H. T.
    Teng, Y. L.
    Chen, T. Y.
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2024, 36 : S294 - S294
  • [24] Assessing Heterogeneity of Treatment Effect in Real-World Data
    Segal, Jodi B.
    Varadhan, Ravi
    Groenwold, Rolf H. H.
    Henderson, Nicholas C.
    Li, Xiaojuan
    Nomura, Kaori
    Kaplan, Sigal
    Ardeshirrouhanifard, Shirin
    Heyward, James
    Nyberg, Fredrik
    Burcu, Mehmet
    ANNALS OF INTERNAL MEDICINE, 2023, 176 (04) : 536 - +
  • [25] Data integration for earthquake disaster using real-world data
    Chuanzhao Tian
    Guoqing Li
    Acta Geophysica, 2020, 68 : 19 - 28
  • [26] Data integration for earthquake disaster using real-world data
    Tian, Chuanzhao
    Li, Guoqing
    ACTA GEOPHYSICA, 2020, 68 (01) : 19 - 28
  • [27] Beyond data sharing: Using real-world data for teaching real-world computational workflows and for benchmarking new methods
    Jansen, Johanna
    Amaro, Rommie
    Tseng, Y. Jane
    Cornell, Wendy
    Esposito, Emilio
    Walters, Pat
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2016, 252
  • [28] ASSESSMENT OF REAL-WORLD DATA SOURCES AND A HYBRID APPROACH IN REAL-WORLD EVIDENCE GENERATION USING UNHARMONIZED DATA SOURCES
    Toh, K. C.
    Goh, C. H.
    Goh, V
    Dong, Z.
    Dumpala, L. S.
    Maity, S.
    Wu, J. Y.
    Kleinman, N.
    Lee, Y.
    VALUE IN HEALTH, 2024, 27 (06) : S407 - S407
  • [29] Assessing Real-World Data Quality: The Application of Patient Registry Quality Criteria to Real-World Data and Real-World Evidence
    Richard E. Gliklich
    Michelle B. Leavy
    Therapeutic Innovation & Regulatory Science, 2020, 54 : 303 - 307
  • [30] Assessing Real-World Data Quality: The Application of Patient Registry Quality Criteria to Real-World Data and Real-World Evidence
    Gliklich, Richard E.
    Leavy, Michelle B.
    THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2020, 54 (02) : 303 - 307
12345